05/28/2026
Did you know?
"Evergreening" is a strategy pharmaceutical companies use to create a monopoly around their drug by filing patents for minor modifications such as dosing amounts and frequency.
Learn more about patents:
Explore the U.S. patents Merck deploys to stymie competition and keep revenues for its blockbuster cancer drug flowing as long as possible.